articleThe LancetMar 1, 2005Closed access

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

EJE. Joanna BaxterLMLinda M. ScottPJPeter J. CampbellCEClare EastNFNasios Fourouclas

University of Cambridge · Addenbrooke's Hospital

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

3,442
total citations
FWCI
107.06
Percentile
100%
References
37
Citations per year

Authors

13

Topics & keywords

Topics
Keywords
  • Polycythaemia
  • Myeloproliferative Disorders
  • Myelofibrosis
  • Biology
  • Point mutation
  • Tyrosine kinase
  • Polycythemia vera
  • Exon
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding